Cannabis Attorney Warns State Operators of Federal Rescheduling Risks

Cannabis attorney Jason Adelstone has issued a warning to state marijuana operators, cautioning them to proceed with caution as the federal government's reclassification of marijuana from Schedule IV to Schedule III remains under legal scrutiny. Adelstone, an attorney with Harris Sliwoski, published an analysis on September 11, highlighting the potential risks for businesses operating under the new federal framework.

The U.S. Court of Appeals for the D.C. Circuit denied an emergency stay on September 9, maintaining the status quo but not making a final ruling on the underlying statutory challenges. Adelstone argues that the denial of the stay does not mean the federal Schedule III order will ultimately survive the litigation. He points to potential drafting problems in the final order and suggests that if the petitioners establish Article III standing, the Attorney General's Schedule III final order could be overturned.

MMJ International Holdings, Inc., along with its subsidiaries MMJ BioPharma Cultivation, Inc., and MMJ BioPharma Labs, Inc., has emphasized the importance of understanding the legal uncertainties surrounding the federal reclassification. Duane Boise, CEO of MMJ International Holdings, stated, "The marijuana industry should read beyond the headline. The court denied an emergency stay. It did not uphold the Schedule III order on the merits. Now a cannabis attorney is warning state operators to protect themselves contractually because the order could still be overturned."

The denial of the stay was a procedural victory for the government and supporters of the new framework, but it did not provide a final judicial endorsement of Schedule III. Adelstone's analysis underscores the ongoing legal challenges and the potential for significant regulatory and contractual disruption. He warns state medical marijuana licensees to be "very careful" about how they proceed and what they put into their contracts, as agreements involving interstate or international commerce under the new framework could be disrupted if the order is ultimately overturned.

The case is far from over, as standing remains an important threshold issue, and the statutory challenges have yet to be fully resolved. Adelstone's warning highlights the regulatory risk that businesses face as they navigate the evolving legal landscape. The outcome of the litigation could have substantial implications for the marijuana industry, with businesses potentially gaining a first-mover advantage if the order survives judicial review, or facing significant disruption if it is vacated.

In the meantime, state operators are being advised to prepare for both outcomes, ensuring that their business strategies and contractual agreements are flexible enough to adapt to the legal uncertainties. The industry now faces two very different potential outcomes: continued operation under the new federal framework or a return to the previous regulatory landscape.